Cannabis

India Globalization Capital (IGC Pharma) is significantly expanding the clinical development of its Alzheimer's drug candidate, IGC-AD1. The company has...

Canopy Growth Corporation has unveiled its most robust operational performance in recent memory with the release of its third-quarter fiscal...

Tilray Brands, Inc. continues to build on its strong January performance with two significant strategic developments. The cannabis and consumer...

Investors are turning their attention to Hydrofarm Holdings Inc as the anticipated release date for its fourth-quarter 2025 financial results...

Investors are positioning themselves ahead of a key financial update from Canadian cannabis producer Canopy Growth. The company's shares closed...

Tilray Brands concluded a challenging January with its equity value experiencing a significant contraction. The company's stock closed the final...

Tilray shares are currently trading near their 52-week lows, a position from which the company is actively pursuing an operational...

Tilray Brands' latest financial report presents investors with a complex picture. The company achieved its highest-ever quarterly revenue, driven by...

Despite an aggressive international growth strategy, Tilray Brands' share price continues to struggle. The company's operational advances, including a new...

Investors in the cannabis sector are searching for stability, and Canopy Growth is no exception to this trend. A palpable...